Wilmer Cutler Pickering Hale and Dorr represented Beam Therapeutics Inc., and Davis Polk & Wardwell advised the underwriters in the offering. Beam Therapeutics Inc. (Nasdaq: BEAM)...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented KALA BIO, Inc. in the transaction. KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company, announced it had entered into...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised Barclays Capital, Inc., as representatives of the initial...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy® Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. MicroStrategy Incorporated...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Arvinas, Inc. on the transaction. Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas”) announced that it entered into a securities purchase agreement with a...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering...
You must be a Standard 1 Year member to access this content.
